S
Sutter Health | Center of Excellence in Diabetes and Endocrinology
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tirzepatide
Ertugliflozin
PF-04971729
BMF-219
MK-8835-059
MK-8835
LY3298176
Parent organization
This site is a part of Sutter Health
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
Status recently updated
The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition...
Not yet enrolling
Enrolling
Weight Gain
Obesity
Drug: Tirzepatide
Drug: Placebo
Locations recently updated
The purpose of this study is to learn more about the safety and efficacy of tirzepatide compared to placebo in children or teenagers with type 2 diab...
Active, not recruiting
Type2 Diabetes
Glucose Metabolism Disorders
Drug: Placebo
Drug: Tirzepatide Dose 2
This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...
Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Metformin
Drug: Placebo to ertugliflozin 5 mg
Trial sponsors
B
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems